Assessment of Severity and Prognosis for Patients With Status Epileptics(SE)

NCT ID: NCT02269137

Last Updated: 2016-01-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-03-31

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To characterize the functional outcomes and prognostic factors for convulsive status epilepticus (SE) and to further develop and validate a simple and practicable scoring system for outcome prediction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Retrospectively study all patients with convulsive SE treated between March, 2008, and November, 2014.
2. Develop a scoring system for outcome prediction.
3. Prospectively validate the predictive accuracy of the scoring system

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Status Epileptics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 30 min or more of (1) continuous clinical seizure activities or (2) recurrent seizure activities without recovery(returning to baseline)between seizures;
* clinical data is complete.

Exclusion Criteria

* hypoglycemia SE;psychogenic SE;any other pseudo-SE
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Xijing Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wen Jiang, MD

Role: STUDY_DIRECTOR

The Department of Neurology, Xijing Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Department of Neurology, Xijing Hospital

Xi'an, Shaanxi, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wen Jiang, MD

Role: CONTACT

02984771319

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Wen Jiang, MD

Role: primary

02984771319

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Xijing-49

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.